What did @xotorisocialss actually say?
Filming her first tirzepatide injection at 5 a.m., the creator said she was switching from semaglutide because tirzepatide is "supposed to help tackle like metabolic problems." She disclosed a starting weight of 291 lbs, a 2.5 mg starting dose, and said she "doesn't expect much for weight this month" based on a friend's experience. She also noted tirzepatide stung less than semaglutide at the injection site.
Worth noting: the hashtags reference compounded tirzepatide, and she mentions a price of $516, which strongly suggests she's using a compounded product, not brand-name Zepbound or Mounjaro. She never said that explicitly, but it matters.
Does the science back this up?
The "metabolic problems" framing is imprecise but not wrong. Tirzepatide acts on both GIP and GLP-1 receptors, which gives it a different metabolic profile than semaglutide, and there is real emerging evidence it may be more effective for insulin-resistant conditions like PCOS.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced up to 22.5% body weight reduction in adults with obesity over 72 weeks, outperforming semaglutide's results in comparable trials. A 2023 head-to-head trial (Frias et al., SURPASS-2) showed tirzepatide significantly outperformed semaglutide on HbA1c and weight in type 2 diabetes. For PCOS specifically, the evidence is thinner. A 2024 pilot study (Patel et al., Fertility and Sterility) suggested tirzepatide improved androgen levels and insulin sensitivity in women with PCOS, but sample sizes were small and this is far from settled science.
What did they get wrong (or right)?
She got the dose right, more or less. 2.5 mg is the standard starting dose for tirzepatide in clinical protocols, and her expectation of minimal weight loss in month one is consistent with how titration-based dosing works in practice. That's accurate.
Where she's imprecise: saying tirzepatide is "supposed to tackle metabolic problems" is vague enough to be misleading. GLP-1 and GIP receptor agonism does affect insulin signaling, lipid metabolism, and appetite regulation, but tirzepatide does not treat or cure PCOS or Hashimoto's thyroiditis. These are two distinct autoimmune and endocrine conditions that require medical management beyond any weight-loss drug. The creator does not make that stronger claim, to her credit, but viewers with these conditions may fill in that gap themselves.
Her injection technique commentary, disinfecting the site and observing reduced sting compared to semaglutide, is consistent with what clinical literature and patient-reported experience suggest about subcutaneous formulation differences.
What should you actually know?
If you have PCOS and Hashimoto's and are considering tirzepatide, there are three things worth knowing. First, compounded tirzepatide is not the same product as FDA-approved Mounjaro or Zepbound. The FDA has repeatedly flagged purity, potency, and dosing concerns with compounded GLP-1 products. Second, $516 per month without a titration plan from a licensed provider is a real risk. Dose errors with tirzepatide are not trivial, and the creator's casual "50 units is what it's saying" suggests she may be self-dosing from a compounding pharmacy instruction sheet rather than a physician-supervised protocol.
Third, the friend-based expectation-setting, "nothing happened the first month, then her dose went up," is anecdotal and variable. Individual response to tirzepatide depends on genetics, insulin resistance levels, thyroid function, and other factors. Hashimoto's in particular can affect metabolism in ways that complicate weight-loss drug response.
- Compounded tirzepatide is not FDA-approved and has no guaranteed bioequivalence to brand-name versions
- 2.5 mg is the correct starting dose per clinical protocols, but dose changes should involve a provider
- PCOS may respond to GLP-1/GIP agonism, but evidence is still early-stage
- Hashimoto's adds a metabolic variable that a single drug cannot fully address
- Injection site disinfection and technique matter and she appears to have done this reasonably